{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:43:59Z","timestamp":1762098239186},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1007\/bf01642903","type":"journal-article","created":{"date-parts":[[2005,6,3]],"date-time":"2005-06-03T07:42:15Z","timestamp":1117784535000},"page":"S28-S35","source":"Crossref","is-referenced-by-count":50,"title":["Pharmacology of antimigraine drugs"],"prefix":"10.1007","volume":"238","author":[{"given":"P. R.","family":"Saxena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. O.","family":"Den Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF00542515","volume":"25","author":"WH Aellig","year":"1983","unstructured":"Aellig WH (1983) Influence of pizotifen and ergotamine on the vasoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man. Eur J Clin Pharmacol 25:759\u2013762","journal-title":"Eur J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1526-4610.1989.hed22904215.x","volume":"29","author":"GW Albers","year":"1989","unstructured":"Albers GW, Simon LT, Hamik A, Peroutka SJ (1989) Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 29:215\u2013218","journal-title":"Headache"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1526-4610.1982.hed2206249.x","volume":"22","author":"T Amano","year":"1982","unstructured":"Amano T, Meyer JS (1982) Cerebrovascular changes in patients with headache during antiserotonergic treatment. Headache 22:249\u2013255","journal-title":"Headache"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1468-2982.1988.0804269.x","volume":"8","author":"E Ansell","year":"1988","unstructured":"Ansell E, Fazzone T, Festenstein R, Johnson ES, Thavalpalan M, Wilkinson M, Wozniak I (1988) Nimodipine in migraine prophylaxis. Cephalalgia 8:269\u2013272","journal-title":"Cephalalgia"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2125.1980.tb01064.x","volume":"9","author":"DN Bateman","year":"1980","unstructured":"Bateman DN, Kahn C, Davies DS (1980) The pharmacokinetics of metoclopramide in man. J Clin Pharmacol 9:371\u2013377","journal-title":"J Clin Pharmacol"},{"key":"CR6","first-page":"53","volume":"5","author":"PO Behan","year":"1980","unstructured":"Behan PO (1980) Prophylactic migraine therapy. J Drug Res 5 (suppl):53\u201357","journal-title":"J Drug Res"},{"key":"CR7","volume-title":"Migraine, clinical, therapeutic, conceptual and research aspects","year":"1987","unstructured":"Blau JN (ed) (1987) Migraine, clinical, therapeutic, conceptual and research aspects. Chapman and Hall, London"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1476-5381.1989.tb11965.x","volume":"97","author":"AH Bom","year":"1989","unstructured":"Bom AH, Heiligers JPC, Saxena PR, Verdouw PD (1989) Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors. Br J Pharmacol 97:383\u2013390","journal-title":"Br J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0028-3908(86)90207-8","volume":"25","author":"PB Bradley","year":"1986","unstructured":"Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563\u2013576","journal-title":"Neuropharmacology"},{"issue":"6","key":"CR10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/03331024870070S6176","volume":"7","author":"J Brand","year":"1987","unstructured":"Brand J, Hadoke M, Perrin VL (1987) Placebo-controlled study of a selective 5-HT1-like agonist, AH25086B, in relief of acute migraine. Cephalalgia 7 (suppl 6):402\u2013403","journal-title":"Cephalalgia"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2165\/00003495-198224050-00002","volume":"24","author":"RN Brogden","year":"1982","unstructured":"Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Domperidone. A review on its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 24:360\u2013400","journal-title":"Drugs"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1990.tb14679.x","volume":"99","author":"MG Buzzi","year":"1990","unstructured":"Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202\u2013206","journal-title":"Br J Pharmacol"},{"issue":"9","key":"CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/J.1468-2982.1989.TB00073.X","volume":"9","author":"FAA Dallas","year":"1989","unstructured":"Dallas FAA, Dixon CM, McCulloch RJ, Saynor DA (1989) The kinetics of 14C-GR43175 in rat and dog. Cephalalgia 9 (suppl 9):53\u201356","journal-title":"Cephalalgia"},{"key":"CR14","unstructured":"Den Boer MO, Villal\u00f2n CM, Heiligers JPC, Saxena PR, Humphrey PPA (1990) The craniovascular effects of sumatriptan. Br J Pharmacol 99:37P"},{"key":"CR15","doi-asserted-by":"crossref","unstructured":"Den Boer MO, Villal\u00f2n CM, Heiligers JPC, Humphrey PPA, Saxena PR (1991) Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (in press)","DOI":"10.1111\/j.1476-5381.1991.tb12173.x"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1526-4610.1982.hed2206268.x","volume":"22","author":"S Diamond","year":"1982","unstructured":"Diamond S, Kudrow L, Stevens J, Shapiro DB (1982) Long-term study of propranolol in the treatment of migraine. Headache 22:268\u2013271","journal-title":"Headache"},{"issue":"6","key":"CR17","first-page":"402","volume":"7","author":"A Doenicke","year":"1987","unstructured":"Doenicke A, Siegel E, Hadoke A, Perrin VL (1987) Initial clinical study of AH25086B, in relief of acute migraine. Cephalalgia 7 (suppl 6):402\u2013403","journal-title":"Cephalalgia"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1476-5381.1989.tb11787.x","volume":"96","author":"W Feniuk","year":"1989","unstructured":"Feniuk W, Humphrey PPA, Perren MJ (1989) The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs. Br J Pharmacol 96:83\u201390","journal-title":"Br J Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1526-4610.1983.hed2304188.x","volume":"23","author":"B Forssman","year":"1983","unstructured":"Forssman B, Lindblad CJ, Zbornikova V (1983) Atenolol for migraine prophylaxis. Headache 23:188\u2013190","journal-title":"Headache"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"139B","DOI":"10.1016\/0002-9149(85)90622-8","volume":"55","author":"HJ Gelmers","year":"1985","unstructured":"Gelmers HJ (1985) Calcium-channel blockers in the treatment of migraine. Am J Cardiol 55:139B-143B","journal-title":"Am J Cardiol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-6147(89)90089-8","volume":"10","author":"V Glover","year":"1989","unstructured":"Glover V, Sandler M (1989) Can the vascular and neurogenic theories of migraine finally be reconciled? Trends Pharmacol Sci 10:1\u20133","journal-title":"Trends Pharmacol Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00003495-198325050-00002","volume":"25","author":"RA Harrington","year":"1983","unstructured":"Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC (1983) Metoclopramide. An up-dated view of its pharmacological properties and clinical use. Drugs 25:451\u2013494","journal-title":"Drugs"},{"issue":"7","key":"CR23","first-page":"10","volume":"8","author":"Headache Classification Committee","year":"1988","unstructured":"Headache Classification Committee, International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 (suppl 7):10\u201373","journal-title":"Cephalalgia"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1468-2982.1988.0804279.x","volume":"8","author":"C Hedman","year":"1988","unstructured":"Hedman C, Andersen AR, Andersson PG, Gilhus NG, Kangasniemi P, Olsson JE, Strandman E, Nestvold K, Olesen J (1988) Symptoms of classic migraine attacks: modifications brought about by metoprolol. Cephalalgia 8:279\u2013284","journal-title":"Cephalalgia"},{"key":"CR25","first-page":"1","volume":"2","author":"H Heyck","year":"1969","unstructured":"Heyck H (1969) Pathogenesis of migraine. Res Clin Stud Headache 2:1\u201328","journal-title":"Res Clin Stud Headache"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1476-5381.1988.tb11630.x","volume":"94","author":"PPA Humphrey","year":"1988","unstructured":"Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates IH, Butina D (1988) GR43175, a selective agonist for the 5-HT1-like receptor in the dog saphenous vein. Br J Pharmacol 94:1123\u20131132","journal-title":"Br J Pharmacol"},{"issue":"9","key":"CR27","first-page":"23","volume":"9","author":"PPA Humphrey","year":"1989","unstructured":"Humphrey PPA, Perren MJ, Feniuk W, Connor HE, Oxford AW (1989) The pharmacology of a novel 5-HT1-like receptor agonist, GR43175. Cephalalgia 9 (suppl 9):23\u201333","journal-title":"Cephalalgia"},{"key":"CR28","first-page":"417","volume-title":"Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications","author":"PPA Humphrey","year":"1990","unstructured":"Humphrey PPA, Apperly E, Feniuk W, Perren MJ (1990) A rational approach to identifying a fundamentally new drug for the treatment of migraine. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications. Kluwer, Dordrecht, pp 417\u2013428"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.1983.tb02243.x","volume":"16","author":"JJ Ibraheem","year":"1983","unstructured":"Ibraheem JJ, Paalzow L, Tfelt-Hansen P (1983) Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. Br J Clin Pharmacol 16:695\u2013699","journal-title":"Br J Clin Pharmacol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00335317","volume":"6","author":"CW Kerber","year":"1973","unstructured":"Kerber CW, Newton TH (1973) The macro- and microvasculature of the dura mater. Neuroradiology 6:175\u2013179","journal-title":"Neuroradiology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1468-2982.1982.0204197.x","volume":"2","author":"P Louis","year":"1982","unstructured":"Louis P, Spierings EL (1982) Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study. Cephalalgia 2:197\u2013203","journal-title":"Cephalalgia"},{"issue":"8","key":"CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/03331024880080S805","volume":"8","author":"CH Lucking","year":"1988","unstructured":"Lucking CH, Oestreich W, Schmidt R, Soyka D (1988) Flunarizine vs propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia 8 (suppl 8):21\u201326","journal-title":"Cephalalgia"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1212\/WNL.39.2.284","volume":"39","author":"JC McArthur","year":"1989","unstructured":"McArthur JC, Marek K, Pestronk A, McArthur J, Peroutka SJ (1989) Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects. Neurology 39:284\u2013286","journal-title":"Neurology"},{"key":"CR34","first-page":"219","volume-title":"Neural regulation of brain circulation","author":"E M\u00fcller-Schweinitzer","year":"1986","unstructured":"M\u00fcller-Schweinitzer E (1986) Serotonergic receptors in brain vessels. In: Owman C, Hardebo JE (eds) Neural regulation of brain circulation. Elsevier, Amsterdam, pp 219\u2013234"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-642-66775-6_3","volume-title":"Ergot alkaloids and related compounds. Handbook of experimental pharmacology","author":"E M\u00fcller-Schweinitzer","year":"1978","unstructured":"M\u00fcller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Handbook of experimental pharmacology. Springer, Berlin pp 87\u2013232"},{"issue":"9","key":"CR36","first-page":"93","volume":"9","author":"TH Nielsen","year":"1989","unstructured":"Nielsen TH, Tfelt-Hansen P (1989) Lack of effect of GR43175 on peripheral arteries in man. Cephalalgia 9 (suppl 9):93\u201395","journal-title":"Cephalalgia"},{"issue":"9","key":"CR37","first-page":"47","volume":"9","author":"AA Parsons","year":"1989","unstructured":"Parsons AA, Whalley ET (1989) Characterization of the 5-hydroxytryptamine receptor which mediates contraction of the human isolated basilar artery. Cephalalgia 9 (suppl 9):47\u201351","journal-title":"Cephalalgia"},{"key":"CR38","first-page":"687","volume":"16","author":"SJ Peroutka","year":"1979","unstructured":"Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687\u2013699","journal-title":"Mol Pharmacol"},{"issue":"9","key":"CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/J.1468-2982.1989.TB00071.X","volume":"9","author":"MJ Perren","year":"1989","unstructured":"Perren MJ, Feniuk W, Humphrey PPA (1989) The selective closure of feline arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia 9 (suppl 9):41\u201346","journal-title":"Cephalalgia"},{"issue":"9","key":"CR40","first-page":"63","volume":"9","author":"VL Perrin","year":"1989","unstructured":"Perrin VL, F\u00e4rkkil\u00e4 M, Goasguen J, Doenicke A, Brand J, Tfelt-Hansen P (1989) Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia 9 (suppl 9):63\u201372","journal-title":"Cephalalgia"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2008-1069578","volume":"108","author":"R Puzich","year":"1983","unstructured":"Puzich R, Girke W, Heidrich H, Rischke M (1983) Dopplersonographische Untersuchungen der extrakraniellen Hirngef\u00e4se bei Migr\u00e4ne-Patienten nach Gabe von Ergotamintartrat. Dtsch Med Wochenschr 108:457\u2013461","journal-title":"Dtsch Med Wochenschr"},{"key":"CR42","first-page":"926","volume-title":"The pharmacological basis of therapeutics","author":"TW Rall","year":"1985","unstructured":"Rall TW, Schleifer LS (1985) Oxytocin, prostaglandins, ergot alkaloids and other drugs; toxicolytic agents. In: Goodman-Gilman A, Goodman LS, Rall TW, Murat F (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 926\u2013945"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/bjs.1800520105","volume":"52","author":"GF Rowbotham","year":"1965","unstructured":"Rowbotham GF, Little E (1965) New concepts on the aetiology and vascularization of meningiomata: the mechanism of migraine; the chemical process of cerebrospinal fluid; and the formation of collections of blood or fluid in the subdural space. Br J Surg 52:21\u201324","journal-title":"Br J Surg"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1526-4610.1975.hed1404190.x","volume":"14","author":"RE Ryan Jr","year":"1975","unstructured":"Ryan RE, Jr, Ryan RE (1975) Clonidine \u2014 its use in migraine therapy. Headache 14:190\u2013192","journal-title":"Headache"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.410240607","volume":"24","author":"K Saito","year":"1988","unstructured":"Saito K, Markowitz S, Moskowitz MA (1988) Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 24:732\u2013737","journal-title":"Ann Neurol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1526-4610.1972.hed1202044.x","volume":"12","author":"PR Saxena","year":"1972","unstructured":"Saxena PR (1972) The effects of antimigraine drugs on the vascular responses by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache 12:44\u201354","journal-title":"Headache"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(74)90206-4","volume":"27","author":"PR Saxena","year":"1974","unstructured":"Saxena PR (1974) Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol 27:99\u2013105","journal-title":"Eur J Pharmacol"},{"key":"CR48","first-page":"581","volume-title":"Migraine, clinical, therapeutic, conceptual and research aspects","author":"PR Saxena","year":"1987","unstructured":"Saxena PR (1987) Arteriovenous anastomoses and veins in migraine research. In: Blau JN (ed) Migraine, clinical, therapeutic, conceptual and research aspects. Chapman and Hall, London, pp 581\u2013596"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/acprof:oso\/9780192618108.003.0015","volume-title":"Migraine, a spectrum of ideas","author":"PR Saxena","year":"1990","unstructured":"Saxena PR (1990) Is there still a case for the shunt hypothesis in migraine? In: Sandler M, Collins G (eds) Migraine, a spectrum of ideas. Oxford Medical Publications, Oxford, pp 191\u2013197"},{"key":"CR50","first-page":"162","volume-title":"Migraine, a spectrum of ideas","author":"PR Saxena","year":"1990","unstructured":"Saxena PR (1990) 5-HT receptors and migraine. In: Sandler M, Collins G (eds) Migraine, a spectrum of ideas. Oxford Medical Publications, Oxford, pp 162\u2013190"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1526-4610.1974.hed1304142.x","volume":"13","author":"PR Saxena","year":"1974","unstructured":"Saxena PR, de Vlaam-Schluter GM (1974) Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine. Studies in an experimental model for migraine. Headache 13:142\u2013163","journal-title":"Headache"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0165-6147(89)90238-1","volume":"10","author":"PR Saxena","year":"1989","unstructured":"Saxena PR, Ferrari MD (1989) 5-HT1-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci 10:200\u2013204","journal-title":"Trends Pharmacol Sci"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1982.sp014427","volume":"332","author":"PR Saxena","year":"1982","unstructured":"Saxena PR, Verdouw PD (1982) Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous blood flow. J Physiol 332:501\u2013520","journal-title":"J Physiol"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1476-5381.1984.tb16478.x","volume":"82","author":"PR Saxena","year":"1984","unstructured":"Saxena PR, Verdouw PD (1984) Effects of methysergide and 5-hydroxytryptamine (5-HT) on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol 82:817\u2013826","journal-title":"Br J Pharmacol"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF00584089","volume":"403","author":"PR Saxena","year":"1985","unstructured":"Saxena PR, Verdouw PD (1985) Tissue blood flow and arteriovenous shunting in pigs measured with microspheres of four different sizes. Pfl\u00fcgers Arch 403:128\u2013135","journal-title":"Pfl\u00fcgers Arch"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-2999(71)90218-4","volume":"13","author":"PR Saxena","year":"1971","unstructured":"Saxena PR, van Houwelingen P, Bonta IL (1971) The effect of mianserin hydrochloride on the vascular responses to 5-hydroxytryptamine and related substances. Eur J Pharmacol 13:295\u2013305","journal-title":"Eur J Pharmacol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00512930","volume":"333","author":"PR Saxena","year":"1986","unstructured":"Saxena PR, Duncker DJ, Bom AH, Heiligers JPC, Verdouw PD (1986) Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of \u201c5-hydroxytryptamine1-like\u201d receptors. Naunyn Schmiedebergs Arch Pharmacol 333:198\u2013204","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"9","key":"CR58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/J.1468-2982.1989.TB00068.X","volume":"9","author":"PR Saxena","year":"1989","unstructured":"Saxena PR, Bom AH, Verdouw PD (1989) Characterization of 5-hydroxytryptamine receptors in the cranial vasculature. Cephalalgia 9 (suppl 9):15\u201322","journal-title":"Cephalalgia"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00005344-197911000-00008","volume":"1","author":"HC Schamhardt","year":"1979","unstructured":"Schamhardt HC, Verdouw PD, Van der Hoek TM, Saxena PR (1979) Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis. J Cardiovasc Pharmacol 1:673\u2013686","journal-title":"J Cardiovasc Pharmacol"},{"key":"CR60","first-page":"45","volume-title":"Migraine and beta-blockade","author":"RG Shanks","year":"1985","unstructured":"Shanks RG (1985) Mechanism of action of beta-adrenoceptor antagonists in migraine. In: Carroll JD, Pfaffenrath V, Sjaastad O (eds) Migraine and beta-blockade. H\u00e4ssle, M\u00f6lndal, pp 45\u201353"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0404.1976.tb04788.x","volume":"54","author":"O Sjaastad","year":"1976","unstructured":"Sjaastad O, Dale I (1976) A new (?) clinical headache entity; \u201cchronic paroxysmal hemicrania\u201d. Acta Neurol Scand 54:140\u2013159","journal-title":"Acta Neurol Scand"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1468-2982.1984.0401065.x","volume":"4","author":"O Sjaastad","year":"1984","unstructured":"Sjaastad O, Spierings ELH (1984) Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia 4:65\u201370","journal-title":"Cephalalgia"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4610.1989.hed2907425.x","volume":"29","author":"GD Solomon","year":"1989","unstructured":"Solomon GD (1989) Verapamil in migraine prophylaxis \u2014 a five year review. Headache 29:425\u2013427","journal-title":"Headache"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003495-197203030-00002","volume":"3","author":"TM Speight","year":"1972","unstructured":"Speight TM, Avery TM (1972) Pizotifen (BC 105): a review on its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 3:159\u2013203","journal-title":"Drugs"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.1984.03350180030025","volume":"252","author":"S Stellar","year":"1984","unstructured":"Stellar S, Ahrers SP, Meibohm AR, Reines SA (1984) Migraine prevention with timolol: a double crossover study. J Am Med Assoc 252:2576\u20132580","journal-title":"J Am Med Assoc"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.1980.h2004006.x","volume":"20","author":"P Stensrud","year":"1980","unstructured":"Stensrud P, Sjaastad O (1980) Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 20:204\u2013207","journal-title":"Headache"},{"key":"CR67","first-page":"433","volume-title":"Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications","author":"P Tfelt-Hansen","year":"1990","unstructured":"Tfelt-Hansen P, Nielsen TH (1990) Treatment of migraine with drugs related to 5-hydroxytryptamine. In: Saxena PR, Wallis DI, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-hydroxytryptamine, prospective therapeutic applications. Kluwer, Dordrecht, pp 433\u2013441"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","volume":"69","author":"P Tfelt-Hansen","year":"1984","unstructured":"Tfelt-Hansen P, Standnes B, Kangasniemi P, Hakkarainen H, Olesen J (1984) Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 69:1\u20138","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"CR69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/J.1468-2982.1989.TB00076.X","volume":"9","author":"P Tfelt-Hansen","year":"1989","unstructured":"Tfelt-Hansen P, Brand J, Dano P, Doenicke A, Findley LJ, Iversen HK, Melchart D, Sahlender HM (1989) Early clinical experience with subcutaneous GR43175 in acute migraine: an overview. Cephalalgia 9 (suppl 9):73\u201377","journal-title":"Cephalalgia"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1468-2982.1982.0201033.x","volume":"2","author":"K Weerasuriya","year":"1982","unstructured":"Weerasuriya K, Patel L, Turner P (1982) Beta-adrenoceptor blockade and migraine. Cephalalgia 2:33\u201345","journal-title":"Cephalalgia"},{"key":"CR71","first-page":"44","volume":"5","author":"M Wilkinson","year":"1980","unstructured":"Wilkinson M (1980) The treatment of migraine. J Drug Res 5 (suppl):44\u201352","journal-title":"J Drug Res"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(69)90058-0","volume":"II","author":"E Zaimis","year":"1969","unstructured":"Zaimis E, Hanington E (1969) A possible pharmacological approach to migraine. Lancet II:298\u2013300","journal-title":"Lancet"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01642903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01642903\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01642903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T12:34:36Z","timestamp":1626006876000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01642903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":72,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["BF01642903"],"URL":"https:\/\/doi.org\/10.1007\/bf01642903","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}